Target intelligence / Profile preview

Tumor protein p53-inducible protein 3 (PIG3)

Target
PIG3
Molecular classification
Enzyme, Oxidoreductase, Quinone oxidoreductase, Medium-chain dehydrogenase/reductase family
01

Overview

Tumor protein p53-inducible protein 3 (PIG3) is a p53-regulated gene product and oxidoreductase enzyme involved in the cellular oxidative stress response and induction of apoptosis. It is transcriptionally activated by p53 and contains a consensus p53 binding site in its promoter, with its expression modulated by microsatellite polymorphisms. PIG3 catalyzes NADPH-dependent reduction of quinones, generating reactive oxygen species, and is considered an effector of p53-mediated cell death and tumor suppression. High expression is linked to better prognosis in some cancers such as glioblastoma, making it a prognostic biomarker and a potential therapeutic target[1][3][5][8].

Other names
PIG3TP53I3Quinone oxidoreductase PIG3QORX
02

Mechanism of action

Induction of apoptosis via increased oxidative stress (for compounds acting via p53 pathway or directly on PIG3 expression)[5][3].

03

Biological functions

ApoptosisOxidative stress responseReactive oxygen species generationp53-mediated cell death
04

Disease associations

CancerGlioblastomaLynch syndrome
05

Safety considerations

Potential for increased oxidative stress and cellular toxicity with unregulated or excessive enzyme activity[5].
06

Biomarkers

Prognostic marker in glioblastoma (high PIG3 expression correlates with longer survival and better prognosis)[3].

Beyond the preview

Go deeper on Tumor protein p53-inducible protein 3 (PIG3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor protein p53-inducible protein 3 (PIG3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call